[1]赵麟,郑佳骏,常川,等.成人髓母细胞瘤患者的预后影响因素分析[J].临床神经外科杂志,2020,17(01):52-55.[doi:DOI:10.3969/j.issn.1672-7770.2020.01.012]
 ZHAO Lin,ZHENG Jia-jun,CHANG Chuan,et al.Prognostic factors of medulloblastoma in adults[J].Journal of Clinical Neurosurgery,2020,17(01):52-55.[doi:DOI:10.3969/j.issn.1672-7770.2020.01.012]
点击复制

成人髓母细胞瘤患者的预后影响因素分析()
分享到:

《临床神经外科杂志》[ISSN:1672-7770/CN:32-1727/R]

卷:
17
期数:
2020年01期
页码:
52-55
栏目:
颅内肿瘤专题
出版日期:
2020-02-15

文章信息/Info

Title:
Prognostic factors of medulloblastoma in adults
文章编号:
202001012
作者:
赵麟郑佳骏常川吴刚季晶刘宁胡锦郑康
210029 南京,南京医科大学第一附属医院神经外科(赵麟,季晶,刘宁);复旦大学附属华山医院神经外科(郑佳骏,常川,吴刚,胡锦,郑康)
Author(s):
ZHAO Lin ZHENG Jia-jun CHANG Chuan et al.
Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
关键词:
髓母细胞瘤成人免疫组化突触素
Keywords:
medulloblastoma adults immunohistochemistry synaptophysin
分类号:
R739.41
DOI:
DOI:10.3969/j.issn.1672-7770.2020.01.012
文献标志码:
A
摘要:
目的探讨成人髓母细胞瘤(MB)患者性别、肿瘤部位、免疫组化指标、是否全切、辅助放化疗等临床、病理因素对预后的影响。 方法回顾性分析25例成人髓母细胞瘤患者的临床资料,并对患者的预后进行电话随访。使用Kaplan-Meier曲线和Log-rank检验进行生存分析,寻找影响预后的因素。 结果本组患者中,男性14例(56.0%),女性11例(44.0%),平均年龄为(25.1±5.9)岁。其中,12例患者(48.0%)的肿瘤位于小脑内,13例患者(52.0%)肿瘤突入四脑室;20例患者(80.0%)实现了肿瘤全切;23例患者(92.0%)术后进行了放疗;13例患者(52.0%)术后行化疗。本组患者的5年无进展生存和整体生存率分别为(65.9±10.6)%和(67.5±15.6)%。辅助放疗(P<0.001)和突触素阳性表达(P=0.017)与较好的5年无进展生存相关。在术后行辅助放疗的基础上,再行辅助化疗并无确切疗效(P=0.202)。 结论成人髓母细胞瘤患者术后行辅助放疗是必需的,是否行辅助化疗尚存争议。辅助放疗和突触素阳性表达与较好的预后相关。免疫组化指标对评估成人髓母细胞瘤患者的预后有价值。
Abstract:
Objective To explore the influence of gender,tumor location,immunohistochemical markers,extent of resection, adjuvant radiotherapy and chemotherapy and other clinicopathological factors on the prognosis of adult medulloblastoma(MB). Methods The clinical data of 25 adult MB patients were analyzed retrospectively, and the patients were followed up by telephone. Kaplan Meier curves and log rank tests were used for survival analysis to screen factors affecting the prognosis of adult MB patients. Results Of 25 patients, there were 14 males(56.0%) and 11 females(44.0%) with an average age of(25.1 ± 5.9) years. Among them, 12 patients(48.0%) had tumors in cerebellum, 13 (52.0%) had tumors protruding into the fourth ventricle. 20 patients(80.0%) had total tumor resection; 23 patients(92.0%) underwent postoperative radiotherapy;13 patients(52.0%) underwent postoperative chemotherapy. The 5-year progression free survival rate and overall survival rate were(65.9±10.6)% and(67.5±15.6)% respectively.Adjuvant radiotherapy(P<0.001) and synaptophysin positive expression(P=0.017) were associated with better 5-year progression free survival. On the basis of postoperative adjuvant radiotherapy, adjuvant chemotherapy provided no further benefit(P=0.202). Conclusions Adjuvant radiotherapy is necessary for adult MB patients after operation. Whether adjuvant chemotherapy is necessary or not remains controversial. Adjuvant radiotherapy and positive expression of synaptophysin are associated with better prognosis. The value of immunohistochemistry in evaluating the prognosis of MB patients is established in this research.

相似文献/References:

[1]宋飞,许百男,张军.髓母细胞瘤复发、播散性种植及预后的相关因素分析[J].临床神经外科杂志,2014,(03):193.
[2]夏东彦,张青,马骏,等.成人高级别脑胶质瘤术后替莫唑胺联合依托泊苷治疗的临床运用与观察[J].临床神经外科杂志,2016,(05):340.
 XIA Dong-yan,ZHANG Qing,MA Jun,et al.Clinical application and observation of temozolomide combined with etoposide in the postoperative comprehensive treatment of adult high grade glioma[J].Journal of Clinical Neurosurgery,2016,(01):340.
[3]胡重灵,娄四龙,毛德强,等.成人幕上多发原始神经外胚层肿瘤1例及文献复习[J].临床神经外科杂志,2017,14(01):55.
 HU Chong-ling,LOU Si-long,MAO De-qiang,et al.One case report of audlt supratentorial multiple primitive neuroectodermal tumor and literature review[J].Journal of Clinical Neurosurgery,2017,14(01):55.
[4]刘尚禹,马小军,潘亚文.miRNA在髓母细胞瘤中的作用研究进展[J].临床神经外科杂志,2020,17(02):224.[doi:DOI:10.3969/j.issn.1672-7770.2020.02.023]
 LIU Shang-yu,MA Xiao-jun,PAN Ya-wen..Progress of miRNA in medulloblastoma[J].Journal of Clinical Neurosurgery,2020,17(01):224.[doi:DOI:10.3969/j.issn.1672-7770.2020.02.023]

更新日期/Last Update: 2020-02-19